Holista Colltech Limited · ASX:HCT
Holista Colltech — Shareholder Meeting (May 2023)
17 slides from Holista Colltech's shareholder meeting presentation, May 31, 2023
Slide 1: AGM Presentation May 2023
For personal use only AGM Presentation May 2023 Passion to combine economic success with enriching lives for a sustainable future
Slide 2: Disclaimer
Disclaimer For personal use only This document has been prepared by Holista Colltech Limited and comprises written material/slides for a presentation concerning Holista Colltech Limited and its subsidiaries. The presentation is for information purposes only and does not constitute or form part of an
Slide 3: Building on the Momentum
Building on the Momentum Step-up in sales For personal use only Holista Colltech is an emerging Australian developer of health and wellness products in the US$4.4 trillion Global Health and Wellness Industry* Positive outlook as global health & wellness market continues to grow Sales growth continue
Slide 4: Improved 2022 Results
Improved 2022 Results Increases in sales, customer receipts & op cash flow For personal use only Uptrend in Op Cash Flow Holista delivers second consecutive year of record revenue in FY22 of $8.2m $10 Millions $8 Credible NPAT result in a high inflation and $6 interest rates environment (net loss in
Slide 5: Stringent Cost Management
Stringent Cost Management Remaining focused on this key priority Improving Costs Trend For personal use only 1Q 2022 2Q 2022 3Q 2022 4Q 2022 1Q 2023 $0.0 ▪ Holista does not foresee a need to Millions -$0.5 Total raise capital for the next 12-months Operating -$1.0 Expenses ▪ Focus on cost control an
Slide 6: First Positive Op Cash Flow
First Positive Op Cash Flow Significant increase in operating cash For personal use only Quarterly Net Operating Cash Flow Cost control and Holista recorded its $100 strong rebound in Thousands first positive quarterly Supplements division Op Cash Flow in its $0 contributed to the history in 1Q FY23
Slide 7: Well Placed for 2023
Well Placed for 2023 Growth carrying through into the new year For personal use only Annual Sales Rising to Record High… …with Momentum Extending into 2023 $9 $2 Millions Millions $8 $7 $2 $6 $5 $1 Ovine Collagen Q4 FY22 $4 Infection Control $1 Q1 FY23 $3 Supplement $2 +33% Food Ingredients $0 $1 $0
Slide 8: Dietary Supplements
Dietary Supplements Developments & updates For personal use only The Group markets and sells Largest contributor to Sales of $6M in FY22 - thirty-seven (37) different Group Revenue (~73% steady over FY21 and up propriety supplements and of FY22 Group revenue) owns market-leading 15% over two years v
Slide 9: Healthy Food Ingredients
Healthy Food Ingredients Developments & updates Holista developed the clean-label low GI premix called GI LiteTM for healthy breads, noodles and pasta, as well For personal use only as healthy sugar alternative 80LessTM that are sold to food and drink (F&B) manufacturers around the world * ▪ Deliver
Slide 10: Ovine Collagen
Ovine Collagen Developments & updates For personal use only Division’s FY22 sales increased 23% pcp to $306K (+77% over two years) Holista has a binding sales contract with leading cosmetics manufacturer Behn Meyer Thailand Holista is the only Company producing Australian-made sheep collagen that is
Slide 11: New Collagen Patent
New Collagen Patent Improved processing & new markets For personal use only New global patent filed on 19 May 2023 Patent covers process improvements to extract collagen from animal skin that: ▪ Produces less bioburden (bacteria living on the surface) ▪ Increases speed and efficiency ▪ Reduces costs
Slide 12: Infection Control
Infection Control Developments & updates For personal use only Holista offers a range of all-natural and Slowdown in consumer demand for sanitisers post alcohol-free sanitising solutions that have been proven to be effective against viruses, pandemic including COVID-19 Holista refocusing on B2B mark
Slide 13: Opportunities in the Chinese Market
Opportunities in the Chinese Market Potential upside from the reopening of China For personal use only Holista is exploring a number of business development opportunities in China following: ✓ The reopening of its economy post COVID ✓ Improving relations between the governments of China and Australi
Slide 14: Medium-Term Growth Projects
Medium-Term Growth Projects Potential for significant growth For personal use only Collagen trial with Holista has shipped Sinbio distributed the collagen to Cosmetic manufacturers to Chinese 20kg of its patented 380 cosmetic manufacturers under develop new products with the SOE collagen to Sinbio t
Slide 15: Summary
Summary Growth drivers for 2023 and beyond For personal use only YTD trading conditions point to further growth in 2023 following record revenues in 2022 Dietary Supplements Ovine Collagen • Sales growth expected to • Binding sales agreement with Global wellness trends supportive of continue in 2023
Slide 16: Board of Directors
Board of Directors Expertise to lead the Group forward For personal use only David Deloub Rajen Manicka Loren King Jay Stephenson Roscoe Moore Non-Executive Chair Exec Director & CEO Non-Executive Director Company Secretary Advisor Over 30 years experience Dr Manicka spent nine Worked in corp financ
Slide 17: Thank You
To join our mailing list please email: update@holistaco.com For personal use only Thank You For further information, please contact: Corporate Matters: investor@holistaco.com General Enquiries: enquiries@holistaco.com Investor/Media Relations: Brendon Lau (m: 0409 341 613, e: brendon@vantagepointpar